Skystar Bio-Pharma (SKBI) Tops Q1 EPS by 8c; Reiterates Outlook
Tweet
Share
E-mailGet Alerts SKBI Hot Sheet
Price: $0.00 --0%
Financial Fact:
Diluted (in dollars per share): 0.57
Today's EPS Names:
NSLR, OCTV, ACB, More
Financial Fact:
Diluted (in dollars per share): 0.57
Today's EPS Names:
NSLR, OCTV, ACB, More
Join SI Premium – FREE
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) reported Q1 EPS of $0.27, $0.08 better than the analyst estimate of $0.19. Revenue for the quarter came in at $7.09 million versus the consensus estimate of $6.71 million.
Reiterates outlook.
Reiterates outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- CI&T Inc (CINT) Misses Q2 EPS by 3c
- Hour Loop, Inc. (HOUR) Reports Q2 EPS of $0.03
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
